ALMS vs ATTO: fair value comparison
Alumis Inc. and Attovia Therapeutics, Inc. · Updated 2026-10-19
ALMS has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. ATTO has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, ALMS currently ranks higher by quality score.
| ALMS | ATTO | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $6.12 | $13.73 |
| 12-month range | $4.51–$30.30 | $13.73–$22.22 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #175 of 301 Healthcare | #177 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| RSI zone | Oversold | Oversold |
| 50/200-day trend | Downtrend | — |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: ALMS fair value analysis · ATTO fair value analysis